Form 8-K Roivant Sciences Ltd. For: Apr 02

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. MIRM
2. MSFT
3. PLTR
4. SPY
5. CSCO
6. KTOS
7. AON
8. TMUS
9. ALHC
10. LBRX

Go back to Form 8-K Roivant Sciences Ltd. For: Apr 02

JPMorgan's Take on Roivant Sciences (ROIV) Buyback and Positive Data Annoucement

April 2, 2024 8:08 AM EDT

JPMorgan analyst Brian Cheng reiterated an Overweight rating on Roivant Sciences (NASDAQ: ROIV).

The analyst comments "Before market open this morning, Roivant announced up to a $1.5bn stock buyback program and positive top-line data from its Ph 2 NEPTUNE brepocitinib study in... More

Truist Securities sees Roivant Sciences (ROIV) shares up today on positive brepocitinib data

April 2, 2024 8:04 AM EDT

Truist Securities analyst Robyn Karnauskas reiterated a Buy rating and $23.00 price target on Roivant Sciences (NASDAQ: ROIV), saying positive brepocitinib data supports potential success in NIU.

The analyst commented, "We believe Roivant shares could be up today following announcement of positive Ph2 results for... More